Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
DATPT
Cat. No.:
0225LY-1327
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
DATPT is a small-molecule peptide mimetic that reduces the production of inflammatory cytokines and reactive oxygen species by inhibiting SNX9-p47phox interactions and ATP production, making it a candidate for sepsis treatment.
Synonym:
2891582-75-3; N2-(2-(2-(2-Aminoethoxy)ethoxy)ethyl)-6-(4-(tert-butyl)phenyl)-N4-((tetrahydrofuran-2-yl)methyl)-1,3,5-triazine-2,4-diamine hydrochloride
CAS No.:
2891582-75-3
Compound CID:
164946872
Formula:
C24H39ClN6O3
Formula Weight:
495.06
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
DATPT can be used in signal transduction research to investigate the modulation of specific kinase pathways in tumor development.
Library Information
Target:
Microbial growth inhibition
Pathways:
NF-κB signaling; Microbiology/Virology; Immunology/Inflammation; Metabolism
Plate Number:
AOCL-18
Plate Location:
a4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
80 mg/mL; 161.6 mM
